nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—HRH1—Dimenhydrinate—atopic dermatitis	0.362	0.506	CbGbCtD
Levocabastine—HRH1—Loratadine—atopic dermatitis	0.177	0.247	CbGbCtD
Levocabastine—HRH1—Diphenhydramine—atopic dermatitis	0.177	0.247	CbGbCtD
Levocabastine—Stinging—Desonide—atopic dermatitis	0.00672	0.0467	CcSEcCtD
Levocabastine—NTSR2—Peptide GPCRs—CCR3—atopic dermatitis	0.0058	0.041	CbGpPWpGaD
Levocabastine—Eyelid oedema—Fluocinolone Acetonide—atopic dermatitis	0.00545	0.0379	CcSEcCtD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.0052	0.0367	CbGpPWpGaD
Levocabastine—NTSR2—Peptide GPCRs—CXCR3—atopic dermatitis	0.00507	0.0359	CbGpPWpGaD
Levocabastine—Lacrimation—Fluocinolone Acetonide—atopic dermatitis	0.00468	0.0325	CcSEcCtD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00463	0.0327	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00415	0.0294	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00348	0.0246	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00335	0.0237	CbGpPWpGaD
Levocabastine—Stinging—Mometasone—atopic dermatitis	0.00324	0.0226	CcSEcCtD
Levocabastine—NTSR2—Peptide GPCRs—CCR5—atopic dermatitis	0.00318	0.0225	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00311	0.022	CbGpPWpGaD
Levocabastine—Lacrimation increased—Fluocinolone Acetonide—atopic dermatitis	0.00299	0.0208	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00279	0.0197	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00273	0.0193	CbGpPWpGaD
Levocabastine—Pharyngitis—Desonide—atopic dermatitis	0.00271	0.0189	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCL22—atopic dermatitis	0.00265	0.0188	CbGpPWpGaD
Levocabastine—NTSR2—G alpha (q) signalling events—TAC1—atopic dermatitis	0.00246	0.0174	CbGpPWpGaD
Levocabastine—NTSR2—G alpha (q) signalling events—NPS—atopic dermatitis	0.00246	0.0174	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00243	0.0172	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00243	0.0172	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00239	0.0169	CbGpPWpGaD
Levocabastine—Erythema—Desonide—atopic dermatitis	0.00238	0.0165	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCL27—atopic dermatitis	0.00237	0.0167	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00225	0.0159	CbGpPWpGaD
Levocabastine—Eye pain—Fluocinolone Acetonide—atopic dermatitis	0.00221	0.0154	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.0022	0.0156	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.0022	0.0156	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00214	0.0151	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CCL17—atopic dermatitis	0.00212	0.015	CbGpPWpGaD
Levocabastine—Visual disturbance—Fluocinolone Acetonide—atopic dermatitis	0.00211	0.0147	CcSEcCtD
Levocabastine—Cough—Desonide—atopic dermatitis	0.00208	0.0144	CcSEcCtD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00193	0.0136	CbGpPWpGaD
Levocabastine—Erythema—Fluocinonide—atopic dermatitis	0.00193	0.0134	CcSEcCtD
Levocabastine—Pharyngitis—Pimecrolimus—atopic dermatitis	0.00192	0.0133	CcSEcCtD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00187	0.0132	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00183	0.0129	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CCL11—atopic dermatitis	0.00171	0.0121	CbGpPWpGaD
Levocabastine—Eye pain—Tacrolimus—atopic dermatitis	0.00168	0.0117	CcSEcCtD
Levocabastine—Erythema—Pimecrolimus—atopic dermatitis	0.00168	0.0117	CcSEcCtD
Levocabastine—Pain—Desonide—atopic dermatitis	0.00166	0.0115	CcSEcCtD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00166	0.0117	CbGpPWpGaD
Levocabastine—Stinging—Prednisolone—atopic dermatitis	0.00165	0.0115	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00163	0.0115	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00163	0.0115	CbGpPWpGaD
Levocabastine—Stinging—Hydrocortisone—atopic dermatitis	0.00161	0.0112	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.0016	0.0113	CbGpPWpGaD
Levocabastine—Pharyngitis—Loratadine—atopic dermatitis	0.00153	0.0106	CcSEcCtD
Levocabastine—Stinging—Triamcinolone—atopic dermatitis	0.00152	0.0105	CcSEcCtD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.0015	0.0106	CbGpPWpGaD
Levocabastine—Cough—Pimecrolimus—atopic dermatitis	0.00147	0.0102	CcSEcCtD
Levocabastine—Dry mouth—Dimenhydrinate—atopic dermatitis	0.00145	0.0101	CcSEcCtD
Levocabastine—Dry mouth—Diphenhydramine—atopic dermatitis	0.00145	0.0101	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCR3—atopic dermatitis	0.00139	0.00985	CbGpPWpGaD
Levocabastine—Stinging—Dexamethasone—atopic dermatitis	0.00138	0.00957	CcSEcCtD
Levocabastine—Stinging—Betamethasone—atopic dermatitis	0.00138	0.00957	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCL22—atopic dermatitis	0.00136	0.00963	CbGpPWpGaD
Levocabastine—Pain—Fluocinonide—atopic dermatitis	0.00135	0.00935	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CCL27—atopic dermatitis	0.00134	0.00945	CbGpPWpGaD
Levocabastine—Visual impairment—Fluocinolone Acetonide—atopic dermatitis	0.00133	0.00926	CcSEcCtD
Levocabastine—Pharyngitis—Mometasone—atopic dermatitis	0.00131	0.00911	CcSEcCtD
Levocabastine—HRH1—IL-4 Signaling Pathway—STAT6—atopic dermatitis	0.00131	0.00923	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00129	0.00914	CbGpPWpGaD
Levocabastine—Somnolence—Dimenhydrinate—atopic dermatitis	0.00126	0.00877	CcSEcCtD
Levocabastine—Somnolence—Diphenhydramine—atopic dermatitis	0.00126	0.00877	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—NPS—atopic dermatitis	0.00124	0.00878	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—TAC1—atopic dermatitis	0.00124	0.00878	CbGpPWpGaD
Levocabastine—Rash—Desonide—atopic dermatitis	0.00122	0.00851	CcSEcCtD
Levocabastine—Dermatitis—Desonide—atopic dermatitis	0.00122	0.0085	CcSEcCtD
Levocabastine—Fatigue—Diphenhydramine—atopic dermatitis	0.00122	0.0085	CcSEcCtD
Levocabastine—Fatigue—Dimenhydrinate—atopic dermatitis	0.00122	0.0085	CcSEcCtD
Levocabastine—Dyspnoea—Pimecrolimus—atopic dermatitis	0.00122	0.0085	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CXCR3—atopic dermatitis	0.00122	0.00861	CbGpPWpGaD
Levocabastine—Headache—Desonide—atopic dermatitis	0.00122	0.00846	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCL27—atopic dermatitis	0.00121	0.00858	CbGpPWpGaD
Levocabastine—Erythema—Fluocinolone Acetonide—atopic dermatitis	0.0012	0.00836	CcSEcCtD
Levocabastine—Pain—Pimecrolimus—atopic dermatitis	0.00117	0.00815	CcSEcCtD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00117	0.00828	CbGpPWpGaD
Levocabastine—Cough—Loratadine—atopic dermatitis	0.00117	0.00812	CcSEcCtD
Levocabastine—Dry mouth—Loratadine—atopic dermatitis	0.00111	0.00775	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00111	0.00787	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCL17—atopic dermatitis	0.00109	0.0077	CbGpPWpGaD
Levocabastine—Cough—Fluocinolone Acetonide—atopic dermatitis	0.00105	0.0073	CcSEcCtD
Levocabastine—Pharyngitis—Tacrolimus—atopic dermatitis	0.00104	0.00725	CcSEcCtD
Levocabastine—Visual disturbance—Prednisolone—atopic dermatitis	0.00102	0.00711	CcSEcCtD
Levocabastine—Asthenia—Dimenhydrinate—atopic dermatitis	0.00102	0.00708	CcSEcCtD
Levocabastine—Asthenia—Diphenhydramine—atopic dermatitis	0.00102	0.00708	CcSEcCtD
Levocabastine—Visual impairment—Tacrolimus—atopic dermatitis	0.00101	0.00704	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.001	0.00709	CbGpPWpGaD
Levocabastine—Cough—Mometasone—atopic dermatitis	0.001	0.00697	CcSEcCtD
Levocabastine—Rash—Fluocinonide—atopic dermatitis	0.000992	0.0069	CcSEcCtD
Levocabastine—Dermatitis—Fluocinonide—atopic dermatitis	0.000991	0.00689	CcSEcCtD
Levocabastine—Headache—Fluocinonide—atopic dermatitis	0.000986	0.00685	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CXCL10—atopic dermatitis	0.000985	0.00696	CbGpPWpGaD
Levocabastine—Somnolence—Loratadine—atopic dermatitis	0.000971	0.00675	CcSEcCtD
Levocabastine—Dry mouth—Mometasone—atopic dermatitis	0.000956	0.00665	CcSEcCtD
Levocabastine—Fatigue—Loratadine—atopic dermatitis	0.000942	0.00655	CcSEcCtD
Levocabastine—Pain—Loratadine—atopic dermatitis	0.000934	0.00649	CcSEcCtD
Levocabastine—Erythema—Tacrolimus—atopic dermatitis	0.000914	0.00636	CcSEcCtD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000904	0.00639	CbGpPWpGaD
Levocabastine—Eye pain—Dexamethasone—atopic dermatitis	0.000896	0.00623	CcSEcCtD
Levocabastine—Eye pain—Betamethasone—atopic dermatitis	0.000896	0.00623	CcSEcCtD
Levocabastine—Rash—Dimenhydrinate—atopic dermatitis	0.000894	0.00622	CcSEcCtD
Levocabastine—Rash—Diphenhydramine—atopic dermatitis	0.000894	0.00622	CcSEcCtD
Levocabastine—Dermatitis—Diphenhydramine—atopic dermatitis	0.000894	0.00621	CcSEcCtD
Levocabastine—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000894	0.00621	CcSEcCtD
Levocabastine—Headache—Diphenhydramine—atopic dermatitis	0.000889	0.00618	CcSEcCtD
Levocabastine—Headache—Dimenhydrinate—atopic dermatitis	0.000889	0.00618	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCL11—atopic dermatitis	0.000878	0.0062	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FCER2—atopic dermatitis	0.000865	0.00612	CbGpPWpGaD
Levocabastine—Rash—Pimecrolimus—atopic dermatitis	0.000865	0.00601	CcSEcCtD
Levocabastine—Dermatitis—Pimecrolimus—atopic dermatitis	0.000864	0.00601	CcSEcCtD
Levocabastine—Headache—Pimecrolimus—atopic dermatitis	0.000859	0.00597	CcSEcCtD
Levocabastine—Visual disturbance—Dexamethasone—atopic dermatitis	0.000854	0.00594	CcSEcCtD
Levocabastine—Visual disturbance—Betamethasone—atopic dermatitis	0.000854	0.00594	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCL5—atopic dermatitis	0.000848	0.00599	CbGpPWpGaD
Levocabastine—Nausea—Dimenhydrinate—atopic dermatitis	0.000843	0.00586	CcSEcCtD
Levocabastine—Nausea—Diphenhydramine—atopic dermatitis	0.000843	0.00586	CcSEcCtD
Levocabastine—Pain—Fluocinolone Acetonide—atopic dermatitis	0.00084	0.00584	CcSEcCtD
Levocabastine—Dyspnoea—Mometasone—atopic dermatitis	0.000836	0.00581	CcSEcCtD
Levocabastine—Nausea—Pimecrolimus—atopic dermatitis	0.000815	0.00566	CcSEcCtD
Levocabastine—Fatigue—Mometasone—atopic dermatitis	0.000808	0.00562	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CCL22—atopic dermatitis	0.000805	0.00569	CbGpPWpGaD
Levocabastine—Pain—Mometasone—atopic dermatitis	0.000802	0.00557	CcSEcCtD
Levocabastine—Cough—Tacrolimus—atopic dermatitis	0.000798	0.00555	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000788	0.00557	CbGpPWpGaD
Levocabastine—Asthenia—Loratadine—atopic dermatitis	0.000784	0.00545	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCR5—atopic dermatitis	0.000764	0.0054	CbGpPWpGaD
Levocabastine—Dry mouth—Tacrolimus—atopic dermatitis	0.000761	0.00529	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CCL27—atopic dermatitis	0.000717	0.00507	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCR3—atopic dermatitis	0.000715	0.00506	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000702	0.00496	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—NPS—atopic dermatitis	0.000702	0.00496	CbGpPWpGaD
Levocabastine—Rash—Loratadine—atopic dermatitis	0.000689	0.00479	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000689	0.00487	CbGpPWpGaD
Levocabastine—Dermatitis—Loratadine—atopic dermatitis	0.000688	0.00478	CcSEcCtD
Levocabastine—Headache—Loratadine—atopic dermatitis	0.000684	0.00476	CcSEcCtD
Levocabastine—Asthenia—Mometasone—atopic dermatitis	0.000673	0.00468	CcSEcCtD
Levocabastine—HRH1—IL-4 Signaling Pathway—IL4—atopic dermatitis	0.000667	0.00472	CbGpPWpGaD
Levocabastine—Dyspnoea—Tacrolimus—atopic dermatitis	0.000665	0.00463	CcSEcCtD
Levocabastine—Somnolence—Tacrolimus—atopic dermatitis	0.000663	0.00461	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—IL5—atopic dermatitis	0.000653	0.00461	CbGpPWpGaD
Levocabastine—Nausea—Loratadine—atopic dermatitis	0.000649	0.00451	CcSEcCtD
Levocabastine—Visual impairment—Prednisolone—atopic dermatitis	0.000646	0.00449	CcSEcCtD
Levocabastine—Fatigue—Tacrolimus—atopic dermatitis	0.000643	0.00447	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CCL17—atopic dermatitis	0.000643	0.00455	CbGpPWpGaD
Levocabastine—Pain—Tacrolimus—atopic dermatitis	0.000638	0.00444	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—NPS—atopic dermatitis	0.000638	0.00451	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—TAC1—atopic dermatitis	0.000638	0.00451	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCR3—atopic dermatitis	0.000625	0.00442	CbGpPWpGaD
Levocabastine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000619	0.0043	CcSEcCtD
Levocabastine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000618	0.0043	CcSEcCtD
Levocabastine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000615	0.00428	CcSEcCtD
Levocabastine—Pharyngitis—Triamcinolone—atopic dermatitis	0.000612	0.00426	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000606	0.00429	CbGpPWpGaD
Levocabastine—Visual impairment—Methylprednisolone—atopic dermatitis	0.000593	0.00412	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—IL5—atopic dermatitis	0.000593	0.00419	CbGpPWpGaD
Levocabastine—Rash—Mometasone—atopic dermatitis	0.000591	0.00411	CcSEcCtD
Levocabastine—Dermatitis—Mometasone—atopic dermatitis	0.000591	0.00411	CcSEcCtD
Levocabastine—Headache—Mometasone—atopic dermatitis	0.000587	0.00408	CcSEcCtD
Levocabastine—Erythema—Prednisolone—atopic dermatitis	0.000584	0.00406	CcSEcCtD
Levocabastine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000583	0.00405	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—KIF3A—atopic dermatitis	0.000573	0.00405	CbGpPWpGaD
Levocabastine—Erythema—Hydrocortisone—atopic dermatitis	0.00057	0.00397	CcSEcCtD
Levocabastine—Nausea—Mometasone—atopic dermatitis	0.000557	0.00387	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000557	0.00393	CbGpPWpGaD
Levocabastine—Visual impairment—Betamethasone—atopic dermatitis	0.000539	0.00375	CcSEcCtD
Levocabastine—Visual impairment—Dexamethasone—atopic dermatitis	0.000539	0.00375	CcSEcCtD
Levocabastine—Erythema—Triamcinolone—atopic dermatitis	0.000537	0.00373	CcSEcCtD
Levocabastine—Erythema—Methylprednisolone—atopic dermatitis	0.000536	0.00373	CcSEcCtD
Levocabastine—Asthenia—Tacrolimus—atopic dermatitis	0.000535	0.00372	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000529	0.00374	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—NFKBIA—atopic dermatitis	0.000526	0.00372	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCL11—atopic dermatitis	0.000518	0.00366	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CMA1—atopic dermatitis	0.000518	0.00366	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000505	0.00357	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—STAT6—atopic dermatitis	0.000487	0.00345	CbGpPWpGaD
Levocabastine—Erythema—Dexamethasone—atopic dermatitis	0.000487	0.00339	CcSEcCtD
Levocabastine—Erythema—Betamethasone—atopic dermatitis	0.000487	0.00339	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CCL5—atopic dermatitis	0.000479	0.00339	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000471	0.00333	CbGpPWpGaD
Levocabastine—Rash—Tacrolimus—atopic dermatitis	0.00047	0.00327	CcSEcCtD
Levocabastine—Dermatitis—Tacrolimus—atopic dermatitis	0.00047	0.00327	CcSEcCtD
Levocabastine—Cough—Triamcinolone—atopic dermatitis	0.000469	0.00326	CcSEcCtD
Levocabastine—Headache—Tacrolimus—atopic dermatitis	0.000467	0.00325	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CXCL8—atopic dermatitis	0.000462	0.00326	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.00046	0.00325	CbGpPWpGaD
Levocabastine—Dry mouth—Triamcinolone—atopic dermatitis	0.000447	0.00311	CcSEcCtD
Levocabastine—Nausea—Tacrolimus—atopic dermatitis	0.000443	0.00308	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCL5—atopic dermatitis	0.000435	0.00308	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000432	0.00305	CbGpPWpGaD
Levocabastine—Erythema—Prednisone—atopic dermatitis	0.000424	0.00295	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CCR3—atopic dermatitis	0.000423	0.00299	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000423	0.00299	CbGpPWpGaD
Levocabastine—Pain—Prednisolone—atopic dermatitis	0.000408	0.00283	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—CCL22—atopic dermatitis	0.000403	0.00285	CbGpPWpGaD
Levocabastine—Fatigue—Hydrocortisone—atopic dermatitis	0.000401	0.00279	CcSEcCtD
Levocabastine—Pain—Hydrocortisone—atopic dermatitis	0.000398	0.00277	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCR5—atopic dermatitis	0.000392	0.00277	CbGpPWpGaD
Levocabastine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000391	0.00272	CcSEcCtD
Levocabastine—Fatigue—Triamcinolone—atopic dermatitis	0.000378	0.00263	CcSEcCtD
Levocabastine—Fatigue—Methylprednisolone—atopic dermatitis	0.000377	0.00262	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—NPS—atopic dermatitis	0.000377	0.00266	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TAC1—atopic dermatitis	0.000377	0.00266	CbGpPWpGaD
Levocabastine—Pain—Triamcinolone—atopic dermatitis	0.000375	0.00261	CcSEcCtD
Levocabastine—HRH1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000374	0.00264	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—NPS—atopic dermatitis	0.000374	0.00264	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCR3—atopic dermatitis	0.000369	0.00261	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL27—atopic dermatitis	0.000359	0.00254	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL5—atopic dermatitis	0.00035	0.00248	CbGpPWpGaD
Levocabastine—Fatigue—Dexamethasone—atopic dermatitis	0.000343	0.00238	CcSEcCtD
Levocabastine—Fatigue—Betamethasone—atopic dermatitis	0.000343	0.00238	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000341	0.00241	CbGpPWpGaD
Levocabastine—Pain—Dexamethasone—atopic dermatitis	0.00034	0.00236	CcSEcCtD
Levocabastine—Pain—Betamethasone—atopic dermatitis	0.00034	0.00236	CcSEcCtD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000334	0.00236	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000334	0.00236	CbGpPWpGaD
Levocabastine—Asthenia—Hydrocortisone—atopic dermatitis	0.000334	0.00232	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000324	0.00229	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL17—atopic dermatitis	0.000322	0.00227	CbGpPWpGaD
Levocabastine—Asthenia—Triamcinolone—atopic dermatitis	0.000314	0.00219	CcSEcCtD
Levocabastine—Asthenia—Methylprednisolone—atopic dermatitis	0.000314	0.00218	CcSEcCtD
Levocabastine—Rash—Prednisolone—atopic dermatitis	0.000301	0.00209	CcSEcCtD
Levocabastine—Dermatitis—Prednisolone—atopic dermatitis	0.0003	0.00209	CcSEcCtD
Levocabastine—Fatigue—Prednisone—atopic dermatitis	0.000299	0.00208	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CXCL10—atopic dermatitis	0.000299	0.00211	CbGpPWpGaD
Levocabastine—Headache—Prednisolone—atopic dermatitis	0.000299	0.00208	CcSEcCtD
Levocabastine—Rash—Hydrocortisone—atopic dermatitis	0.000293	0.00204	CcSEcCtD
Levocabastine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000293	0.00204	CcSEcCtD
Levocabastine—Headache—Hydrocortisone—atopic dermatitis	0.000292	0.00203	CcSEcCtD
Levocabastine—Asthenia—Dexamethasone—atopic dermatitis	0.000285	0.00198	CcSEcCtD
Levocabastine—Asthenia—Betamethasone—atopic dermatitis	0.000285	0.00198	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000283	0.002	CbGpPWpGaD
Levocabastine—Nausea—Prednisolone—atopic dermatitis	0.000283	0.00197	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000278	0.00196	CbGpPWpGaD
Levocabastine—Nausea—Hydrocortisone—atopic dermatitis	0.000276	0.00192	CcSEcCtD
Levocabastine—Rash—Triamcinolone—atopic dermatitis	0.000276	0.00192	CcSEcCtD
Levocabastine—Dermatitis—Triamcinolone—atopic dermatitis	0.000276	0.00192	CcSEcCtD
Levocabastine—Rash—Methylprednisolone—atopic dermatitis	0.000276	0.00192	CcSEcCtD
Levocabastine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000275	0.00192	CcSEcCtD
Levocabastine—Headache—Triamcinolone—atopic dermatitis	0.000275	0.00191	CcSEcCtD
Levocabastine—Headache—Methylprednisolone—atopic dermatitis	0.000274	0.0019	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000261	0.00184	CbGpPWpGaD
Levocabastine—Nausea—Triamcinolone—atopic dermatitis	0.00026	0.00181	CcSEcCtD
Levocabastine—Nausea—Methylprednisolone—atopic dermatitis	0.00026	0.00181	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—CCL11—atopic dermatitis	0.000259	0.00183	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCL5—atopic dermatitis	0.000257	0.00182	CbGpPWpGaD
Levocabastine—Rash—Betamethasone—atopic dermatitis	0.000251	0.00174	CcSEcCtD
Levocabastine—Rash—Dexamethasone—atopic dermatitis	0.000251	0.00174	CcSEcCtD
Levocabastine—Dermatitis—Betamethasone—atopic dermatitis	0.000251	0.00174	CcSEcCtD
Levocabastine—Dermatitis—Dexamethasone—atopic dermatitis	0.000251	0.00174	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—IL2—atopic dermatitis	0.000249	0.00176	CbGpPWpGaD
Levocabastine—Headache—Dexamethasone—atopic dermatitis	0.000249	0.00173	CcSEcCtD
Levocabastine—Headache—Betamethasone—atopic dermatitis	0.000249	0.00173	CcSEcCtD
Levocabastine—Asthenia—Prednisone—atopic dermatitis	0.000248	0.00173	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000247	0.00175	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000247	0.00175	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000243	0.00172	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NGF—atopic dermatitis	0.000238	0.00168	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCL8—atopic dermatitis	0.000237	0.00168	CbGpPWpGaD
Levocabastine—Nausea—Dexamethasone—atopic dermatitis	0.000236	0.00164	CcSEcCtD
Levocabastine—Nausea—Betamethasone—atopic dermatitis	0.000236	0.00164	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CCR5—atopic dermatitis	0.000232	0.00164	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL2—atopic dermatitis	0.000226	0.0016	CbGpPWpGaD
Levocabastine—Rash—Prednisone—atopic dermatitis	0.000218	0.00152	CcSEcCtD
Levocabastine—Dermatitis—Prednisone—atopic dermatitis	0.000218	0.00152	CcSEcCtD
Levocabastine—Headache—Prednisone—atopic dermatitis	0.000217	0.00151	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—CCR3—atopic dermatitis	0.000211	0.00149	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL22—atopic dermatitis	0.000207	0.00146	CbGpPWpGaD
Levocabastine—Nausea—Prednisone—atopic dermatitis	0.000206	0.00143	CcSEcCtD
Levocabastine—HRH1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000203	0.00143	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NFKBIA—atopic dermatitis	0.000196	0.00139	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000196	0.00139	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—TAC1—atopic dermatitis	0.000188	0.00133	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—NPS—atopic dermatitis	0.000188	0.00133	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000185	0.00131	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL27—atopic dermatitis	0.000184	0.0013	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000178	0.00126	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000169	0.00119	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL17—atopic dermatitis	0.000165	0.00117	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000152	0.00108	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000149	0.00106	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCL8—atopic dermatitis	0.00014	0.00099	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL2—atopic dermatitis	0.000134	0.000946	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL6—atopic dermatitis	0.000133	0.000941	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL11—atopic dermatitis	0.000133	0.000941	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FCER2—atopic dermatitis	0.000131	0.000928	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL5—atopic dermatitis	0.000129	0.000909	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MAPK8—atopic dermatitis	0.000123	0.00087	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL22—atopic dermatitis	0.000122	0.000863	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000119	0.000845	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCR5—atopic dermatitis	0.000116	0.000819	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL27—atopic dermatitis	0.000109	0.000769	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCR3—atopic dermatitis	0.000109	0.000767	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000107	0.000753	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—NPS—atopic dermatitis	0.000107	0.000753	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000104	0.000738	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—IL5—atopic dermatitis	9.9e-05	0.0007	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL17—atopic dermatitis	9.76e-05	0.00069	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—TAC1—atopic dermatitis	9.67e-05	0.000684	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—NPS—atopic dermatitis	9.67e-05	0.000684	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCR3—atopic dermatitis	9.48e-05	0.00067	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	9.2e-05	0.00065	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL5—atopic dermatitis	8.99e-05	0.000636	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KIF3A—atopic dermatitis	8.7e-05	0.000615	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL10—atopic dermatitis	8.44e-05	0.000597	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL6—atopic dermatitis	7.86e-05	0.000556	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL11—atopic dermatitis	7.86e-05	0.000556	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CMA1—atopic dermatitis	7.86e-05	0.000556	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL10—atopic dermatitis	7.67e-05	0.000542	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—STAT6—atopic dermatitis	7.39e-05	0.000523	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCL5—atopic dermatitis	7.27e-05	0.000514	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL8—atopic dermatitis	7e-05	0.000495	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	6.98e-05	0.000493	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL5—atopic dermatitis	6.6e-05	0.000466	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCR5—atopic dermatitis	6.55e-05	0.000463	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCR3—atopic dermatitis	6.41e-05	0.000453	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	5.95e-05	0.00042	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NPS—atopic dermatitis	5.71e-05	0.000404	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TAC1—atopic dermatitis	5.71e-05	0.000404	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	5.6e-05	0.000396	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL5—atopic dermatitis	5.31e-05	0.000375	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	4.53e-05	0.00032	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.96e-05	0.00028	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL5—atopic dermatitis	3.9e-05	0.000276	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	3.78e-05	0.000267	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NGF—atopic dermatitis	3.61e-05	0.000255	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	3.59e-05	0.000254	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCR5—atopic dermatitis	3.51e-05	0.000248	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL2—atopic dermatitis	3.44e-05	0.000243	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	2.98e-05	0.00021	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	2.12e-05	0.00015	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL2—atopic dermatitis	2.03e-05	0.000143	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL6—atopic dermatitis	2.02e-05	0.000143	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	1.87e-05	0.000132	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL6—atopic dermatitis	1.19e-05	8.43e-05	CbGpPWpGaD
